2-[4-(4-Methoxyphenyl)piperazin-1-yl]ethanamine → 3-{2-[4-(4-Methoxyphenyl)piperazin-1-yl]ethyl}aminomethyl-5-methyl-1-phenylpyrazole
反応式
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]2[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][NH2:17])[CH2:11][CH2:10]2)=[CH:5][CH:4]=1.[CH3:18][C:19]1[N:23]([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)[N:22]=[C:21]([CH:30]=O)[CH:20]=1>>[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]([N:9]2[CH2:10][CH2:11][N:12]([CH2:15][CH2:16][NH:17][CH2:30][C:21]3[CH:20]=[C:19]([CH3:18])[N:23]([C:24]4[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=4)[N:22]=3)[CH2:13][CH2:14]2)=[CH:7][CH:8]=1参加物
3
実験手順
Compound 37 was prepared using the same method as that of Example 1 except that 4-(4-methoxyphenyl)piperazin-1-ylethylamine and 5-methyl-1-phenylpyrazole-3-carbaldehyde were used.
出典と根拠
- ORDレコード
- ord-86e455b50ad1429ea5df356f17b40dfe
- 出典データセット
- uspto-grants-2009_06
- 特許番号
- US07544686B2
反応ノート
読み込み中…